Akumentis Healthcare, a pharmaceutical company, reported a profit of Rs 66 crore in the fiscal year ending March 2025, marking a 16.8% increase compared to FY24. The company achieved this growth on the back of consistent revenue and controlled operating costs.
Akumentis’ revenue from operations grew by 9% to Rs 433.5 crore in FY25 from Rs 398 crore in FY24, according to its financial statement sourced from the Registrar of Companies (RoC).
/filters:format(webp)/entrackr/media/media_files/2025/09/24/akumentis-financials-2025-09-24-11-09-02.png)
Akumentis Healthcare operates on a branded formulations model, focusing on prescription-driven pharmaceuticals…

![[CITYPNG.COM]White Google Play PlayStore Logo – 1500×1500](https://startupnews.fyi/wp-content/uploads/2025/08/CITYPNG.COMWhite-Google-Play-PlayStore-Logo-1500x1500-1-630x630.png)